New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
10:01 EDTLH, HSNI, EGRX, FLXN, DGX, IBP, CNCE, HAR, LINTA, TLMROn The Fly: Analyst Initiation Summary
Concert Pharmaceuticals (CNCE) initiated with a Buy at UBS and an Outperform at JMP Securities... Eagle Pharmaceuticals (EGRX) initiated with a Buy at Cantor and an Overweight at Piper Jaffray... Talmer Bancorp (TLMR) initiated with an Outperform at Keefe Bruyette, an Overweight at JPMorgan, a Strong Buy at Raymond James and an Outperform at RBC Capital... HSN, Inc. (HSNI) initiated with a Buy at UBS... Installed Building Products (IBP) initiated with a Buy at Deutsche Bank and a Neutral at SunTrust... Liberty Interactive (LINTA) initiated with a Buy at UBS and Craig-Hallum... Flexion (FLXN) initiated with a Buy at Needham... LabCorp (LH) assumed with a Neutral at Piper Jaffray... Quest Diagnostics (DGX) assumed with a Neutral at Piper Jaffray... Harman (HAR) initiated with an Outperform at Raymond James.
News For CNCE;EGRX;TLMR;IBP;HSNI;LINTA;DGX;LH;HAR;FLXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
07:08 EDTDGXQuest Diagnostics backs FY15 adjusted EPS view $4.70-$4.85, consensus $4.78
Subscribe for More Information
07:06 EDTDGXQuest Diagnostics reports Q1 adjusted EPS $1.05, consensus $1.04
Subscribe for More Information
April 22, 2015
17:23 EDTHARNokia approaches Apple, Amazon, Facebook in sale of maps unit, Bloomberg says
Subscribe for More Information
15:50 EDTDGXNotable companies reporting before tomorrow's open
Subscribe for More Information
09:07 EDTHSNIHSN, Inc. names John Aylward Chief Marketing Officer for HSN
Subscribe for More Information
April 21, 2015
08:14 EDTLH, DGXQuest Diagnostics and Inserm launch BRCA Share initiative
Quest Diagnostics (DGX) and Inserm, the French National Institute of Health and Medical Research institution, launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. The program's goal is to accelerate research on BRCA gene mutations, particularly variants of uncertain significance, to improve the ability of clinical laboratory diagnostics to predict which individuals are at risk of developing hereditary breast and ovarian cancers. Laboratory Corporation of America Holdings (LH) is the first participant in the initiative, which is structured as a user group. B
06:40 EDTLH, DGXStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information
April 20, 2015
07:33 EDTHARHarman reinstated with an Overweight at JPMorgan
Subscribe for More Information
07:02 EDTEGRXEagle Pharmaceuticals price target raised to $75 from $55 at Piper Jaffray
Subscribe for More Information
April 15, 2015
12:32 EDTDGXFocus Diagnostics announced FDA clearance for Simplexa Group A Strep Direct Kit
Subscribe for More Information
08:51 EDTFLXNFlexion weakness creates attractive entry point, says RBC Capital
After meeting with Flexion's management, RBC Capital says the company's story is on track, while its catalysts are getting closer as two data points are on track to be reported in Q4. The firm reiterates a $41 price target and Outperform rating on the shares.
April 14, 2015
11:05 EDTEGRXEagle Pharmaceuticals price target raised to $65 from $51 at Cantor
Subscribe for More Information
08:03 EDTEGRXTeva, Eagle announce NDA for bendamustine HCI accepted for filing
Subscribe for More Information
April 13, 2015
13:25 EDTEGRXEagle Pharmaceuticals appoints Fibrocell CEO to board of directors
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use